Doubling the speed of cell line development in a large pharmaceutical company

In this application note, Advanced Instruments describes how Solentim’s VIPS™ technology has helped the Cell Line Development group at Janssen R&D halve the time to develop the final cell cultures for manufacturing new biologic drugs, while still satisfying the clonality requirements of the Medicines’ Regulators.